Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Engene Holdings Inc (ENGN)

Engene Holdings Inc (ENGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Engene Holdings Inc 4868 RUE LEVY SUITE 220 SAINT-LAURENT A8 H4R 2P1 CAN

https://engene.com Employees: 57 P: 514-332-4888

Sector:

Medical

Description:

enGene Holdings Inc. is a clinical-stage biotechnology company pioneering novel non-viral gene therapies for local administration into mucosal tissues. enGene Holdings Inc., formerly known as Forbion European Acquisition Corp., is based in MONTREAL.

Key Statistics

Overview:

Market Capitalization, $K 546,330
Enterprise Value, $K 395,800
Shares Outstanding, K 64,578
Annual Sales, $ 0 K
Annual Net Income, $ -55,140 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -28,990 K
EBIT, $ -101,140 K
EBITDA, $ -101,050 K
60-Month Beta -0.28
% of Insider Shareholders 10.40%
% of Institutional Shareholders 64.16%
Float, K 57,862
% Float 89.60%
Short Volume Ratio 0.38

Growth:

1-Year Return 28.38%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.57 on 09/11/25
Next Earnings Date 12/18/25 [--]
Earnings Per Share ttm -1.90
EPS Growth vs. Prev Qtr -11.76%
EPS Growth vs. Prev Year -78.12%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Next Ex-Dividends Date 12/24/14
Dividend Payout Ratio 0.00%

ENGN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -39.86%
Return-on-Assets % -34.15%
Profit Margin % 0.00%
Debt/Equity 0.09
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.27
Book Value/Share 3.93
Interest Coverage -18.70
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar